UK MHRA Notes Concern Over Medtech’s Mid-2023 Deadline – But Still No Draft Law Progress
Executive Summary
The One Agency initiative, patient safety, methods of funding and recruitment needs were pressing discussion themes during the MHRA’s April 2022 board meeting held in public.